US 10265397
Formulation for photodynamic therapy
granted A61KA61K41/0057A61K47/32
Quick answer
US patent 10265397 (Formulation for photodynamic therapy) held by SANOCHEMIA PHARMAZEUTIKA AG expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SANOCHEMIA PHARMAZEUTIKA AG
- Grant date
- Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 3
- CPC classes
- A61K, A61K41/0057, A61K47/32, A61K47/58, A61K47/60